Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 5
Submit an article Journal homepage
71
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Aliskiren: clinical experience and future perspectives of renin inhibition

Kalathil K Sureshkumar Allegheny General Hospital, Division of Nephrology and Hypertension, 320 East North Avenue, Pittsburgh, PA 15212, USA +1 412 359 3319; +1 412 359 4136; [email protected]
, MD FRCP,
Sapna Vasudevan Veteran's Administration Primary Care, 100 Ridge Avenue, Washington, PA 15301, USA
, MD,
Richard J Marcus Allegheny General Hospital, Division of Nephrology and Hypertension, 320 East North Avenue, Pittsburgh, PA 15212, USA +1 412 359 3319; +1 412 359 4136; [email protected]
, MD,
Sabiha M Hussain Allegheny General Hospital, Division of Nephrology and Hypertension, 320 East North Avenue, Pittsburgh, PA 15212, USA +1 412 359 3319; +1 412 359 4136; [email protected]
, MD &
Rita L McGill Allegheny General Hospital, Division of Nephrology and Hypertension, 320 East North Avenue, Pittsburgh, PA 15212, USA +1 412 359 3319; +1 412 359 4136; [email protected]
, MD
Pages 825-837 | Published online: 17 Mar 2008

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Steven G. Chrysant, Alexander V. Murray, Uta C. Hoppe, Dan Dattani, Samir Patel, Shannon Ritter & Jack Zhang. (2010) Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension. Current Medical Research and Opinion 26:12, pages 2841-2849.
Read now
David W Laight. (2009) Therapeutic inhibition of the renin angiotensin aldosterone system. Expert Opinion on Therapeutic Patents 19:6, pages 753-759.
Read now

Articles from other publishers (2)

. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:3, pages 260-277.
Crossref
Shridhar Hegde & Michelle Schmidt. 2008. 455 497 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.